Antecip BioVentures II LLC

General

Total Cases15

Active Cases2

Patents244

CourtsD. New Jersey

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

L5

E

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
10/23/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-09535 ( D. NJ )	TEXT ORDER REASSIGNING CASE. Case reassigned to Judge Michael E. Farbiarz for all further proceedings. Judge Madeline Cox Arleo no longer assigned to case. So Ordered by Chief Judge Renee Marie Bumb on 10/23/2024. (jr) (Entered: 10/23/2024)
10/23/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-09535 ( D. NJ )	ORDER CONSOLIDATING CASES FOR ALL PURPOSES, that Civil Action Nos. 24-6489 and 24-9535 are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court. All filings going forward shall be filed in Civil Action No. 24-6489 and that Civil Action No. 24-9535 shall be administratively terminated by the Clerk's office. The 9/27/2024 Letter Order setting the Initial Conference in Civil Action No. 24-6489 (ECF No. 18) shall control with respect to the Initial Disclosures, the Rule 26(f) Conference, submission of the Joint Discovery Plan, and the Initial Scheduling Conference for the Consolidated Actions. Signed by Magistrate Judge Leda D. Wettre on 10/23/2024. (wh) (Entered: 10/23/2024) ORDER CONSOLIDATING CASES FOR ALL PURPOSES, that Civil Action Nos. 24-6489 and 24-9535 are consolidated for all purposes, including discovery, case management, and trial, subject to further order of the Court. All filings going forward shall be filed in Civil Action No. 24-6489 and that Civil Action No. 24-9535 shall be administratively terminated by the Clerk's office. The 9/27/2024 Letter Order setting the Initial Conference in Civil Action No. 24-6489 (ECF No. 18) shall control with respect to the Initial Disclosures, the Rule 26(f) Conference, submission of the Joint Discovery Plan, and the Initial Scheduling Conference for the Consolidated Actions. Signed by Magistrate Judge Leda D. Wettre on 10/23/2024. (wh) (Entered: 10/23/2024)
10/23/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-09535 ( D. NJ )	***Civil Case Terminated pursuant to [10] ORDER CONSOLIDATING CASES FOR ALL PURPOSES. (wh) (Entered: 10/23/2024)
10/21/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-09535 ( D. NJ )	Letter from Axsome to the Hon. Leda D. Wettre, U.S.M.J.. (BATON, WILLIAM) (Entered: 10/21/2024)
10/10/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-09535 ( D. NJ )	WAIVER OF SERVICE Returned Executed by AXSOME THERAPEUTICS, INC., ANTECIP BIOVENTURES II LLC. TEVA PHARMACEUTICALS, INC. waiver sent on 10/3/2024, answer due 12/2/2024. (LIZZA, CHARLES) (Entered: 10/10/2024)
10/03/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-09535 ( D. NJ )	SUMMONS ISSUED as to TEVA PHARMACEUTICALS, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (pm, ) (Entered: 10/03/2024)
10/03/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-09535 ( D. NJ )	AO120 Patent Form filed. (Attachments: # [1] Complaint) (pm, ) (Entered: 10/03/2024)
10/03/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-09535 ( D. NJ )	NOTICE of Appearance by SARAH ANN SULLIVAN on behalf of ANTECIP BIOVENTURES II LLC, AXSOME THERAPEUTICS, INC. (SULLIVAN, SARAH) (Entered: 10/03/2024)
10/03/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:24-CV-09535 ( D. NJ )	NOTICE of Appearance by WILLIAM C. BATON on behalf of ANTECIP BIOVENTURES II LLC, AXSOME THERAPEUTICS, INC. (BATON, WILLIAM) (Entered: 10/03/2024)
10/03/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:23-CV-01695 ( D. NJ )	Set Deadlines as to [85] MOTION to Seal certain portions of the parties' September 10, 2024 Joint Letter to the Hon. Leda D. Wettre, U.S.M.J. (ECF No. 78). Motion set for 11/4/2024 before Magistrate Judge Leda D. Wettre. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (qa, ) (Entered: 10/03/2024) Set Deadlines as to [85] MOTION to Seal certain portions of the parties' September 10, 2024 Joint Letter to the Hon. Leda D. Wettre, U.S.M.J. (ECF No. 78). Motion set for 11/4/2024 before Magistrate Judge Leda D. Wettre. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (qa, ) (Entered: 10/03/2024)